71P A phase I study of binimetinib, a MEK inhibitor, in combination with pembrolizumab in patients with advanced non-small cell lung cancer (NCT03991819)

Authors:
  • CTC. Theriau
    C. Theriau
  • JFJ. Feng
    J. Feng
  • LEL. Eng
    L. Eng
  • FSF.A. Shepherd
    F.A. Shepherd
  • MCM. De Carolis
    M. De Carolis
  • VGV. Glenns
    V. Glenns
  • SKS. Kulkarni
    S. Kulkarni
  • RVR. Vandermeer
    R. Vandermeer
  • UZU. Zurawska-Fortin
    U. Zurawska-Fortin
  • DHD. Hao
    D. Hao
  • LLL. Le
    L. Le
  • IWI. Wozniczka
    I. Wozniczka

Abstract
No abstract available
Funding Information
  • Princess Margaret Cancer Foundation